|
DE19613976C1
(de)
*
|
1996-04-09 |
1997-11-20 |
Gruenenthal Gmbh |
Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
|
|
WO1997045117A1
(en)
*
|
1996-05-29 |
1997-12-04 |
Prototek, Inc. |
Prodrugs of thalidomide and methods for using same as modulators of t-cell function
|
|
HU228769B1
(en)
*
|
1996-07-24 |
2013-05-28 |
Celgene Corp |
Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
|
|
DE19743968C2
(de)
*
|
1997-10-06 |
2002-07-11 |
Gruenenthal Gmbh |
Intravenöse Applikationsform von Thalidomid zur Therapie immunologischer Erkrankungen
|
|
US5955476A
(en)
*
|
1997-11-18 |
1999-09-21 |
Celgene Corporation |
Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
|
|
AU752958B2
(en)
*
|
1997-11-18 |
2002-10-03 |
Celgene Corporation |
Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNFalpha levels
|
|
WO2001041755A2
(en)
*
|
1999-12-02 |
2001-06-14 |
The Regents Of The University Of Michigan |
Topical compositions comprising thalidomide for the treatment of inflammatory diseases
|
|
US7091353B2
(en)
|
2000-12-27 |
2006-08-15 |
Celgene Corporation |
Isoindole-imide compounds, compositions, and uses thereof
|
|
JP4361273B2
(ja)
*
|
2001-02-27 |
2009-11-11 |
アメリカ合衆国 |
潜在的な血管形成阻害剤としてのサリドマイド類似体
|
|
CN100488959C
(zh)
*
|
2003-03-27 |
2009-05-20 |
天津和美生物技术有限公司 |
水溶性的酞胺哌啶酮衍生物
|
|
WO2005016326A2
(en)
*
|
2003-07-11 |
2005-02-24 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Analogs of thalidomide as potential angiogenesis inhibitors
|
|
CN100398534C
(zh)
*
|
2003-09-15 |
2008-07-02 |
天津和美生物技术有限公司 |
合成酞胺哌啶酮及其衍生物的方法
|
|
CA2808646C
(en)
|
2003-09-17 |
2016-08-23 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Thalidomide analogs as tnf-alpha modulators
|
|
US8952895B2
(en)
|
2011-06-03 |
2015-02-10 |
Apple Inc. |
Motion-based device operations
|
|
EP1682126B1
(en)
*
|
2003-10-16 |
2009-07-01 |
Novartis Vaccines and Diagnostics, Inc. |
Substituted benzazoles and use thereof as inhibitors of raf kinase
|
|
ITMI20041113A1
(it)
*
|
2004-06-01 |
2004-09-01 |
Antibioticos Spa |
Processo per la sintesi della talidomide
|
|
US20070155791A1
(en)
*
|
2005-12-29 |
2007-07-05 |
Zeldis Jerome B |
Methods for treating cutaneous lupus using aminoisoindoline compounds
|
|
EP2004614B1
(en)
|
2006-04-13 |
2016-10-19 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Tetrahalogenated compounds useful as inhibitors of angiogenesis
|
|
CA2957226C
(en)
*
|
2008-10-29 |
2018-08-14 |
Celgene Corporation |
Isoindoline compounds for use in the treatment of cancer
|
|
US8927725B2
(en)
|
2011-12-02 |
2015-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Thio compounds
|
|
TWI782395B
(zh)
*
|
2016-01-08 |
2022-11-01 |
美商西建公司 |
抗增生化合物，及其醫藥組合物及用途
|
|
US20200199097A1
(en)
*
|
2017-08-21 |
2020-06-25 |
Nanjing Noratech Pharmaceuticals Co., Ltd |
Pomalidomide derivative and preparation method therefor
|
|
CN111499610A
(zh)
*
|
2019-01-31 |
2020-08-07 |
南京诺瑞特医药科技有限公司 |
泊马度胺前体药物盐的多晶型物
|
|
EP3771711A1
(en)
|
2019-07-29 |
2021-02-03 |
Bayer Animal Health GmbH |
Pyrazole derivatives for controlling arthropods
|